Overview

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is : - To determine the maximum tolerated dose (MTD) for PEP005 Topical Gel in patients with actinic keratoses. - To evaluate patients for clinical safety - To determine the systemic absorption of PEP005 Topical Gel
Phase:
Phase 2
Details
Lead Sponsor:
Peplin